2/4
08:44 pm
avbp
Form 4 ArriVent BioPharma, Inc. For: Feb 02 Filed by: LaChapelle Robin
Medium
Report
Form 4 ArriVent BioPharma, Inc. For: Feb 02 Filed by: LaChapelle Robin
2/4
08:43 pm
avbp
Form 4 ArriVent BioPharma, Inc. For: Feb 02 Filed by: Lutzker Stuart
Medium
Report
Form 4 ArriVent BioPharma, Inc. For: Feb 02 Filed by: Lutzker Stuart
2/4
08:41 pm
avbp
Form 4 ArriVent BioPharma, Inc. For: Feb 02 Filed by: Kung Winston
Medium
Report
Form 4 ArriVent BioPharma, Inc. For: Feb 02 Filed by: Kung Winston
2/4
08:40 pm
avbp
Form 4 ArriVent BioPharma, Inc. For: Feb 02 Filed by: Yao Zhengbin
Medium
Report
Form 4 ArriVent BioPharma, Inc. For: Feb 02 Filed by: Yao Zhengbin
2/4
08:40 pm
avbp
Form 4 ArriVent BioPharma, Inc. For: Feb 02 Filed by: Kastenmayer James Paul
Medium
Report
Form 4 ArriVent BioPharma, Inc. For: Feb 02 Filed by: Kastenmayer James Paul
2/3
04:05 pm
avbp
Form 4 ArriVent BioPharma, Inc. For: Dec 10 Filed by: HILLHOUSE INVESTMENT MANAGEMENT, LTD.
Low
Report
Form 4 ArriVent BioPharma, Inc. For: Dec 10 Filed by: HILLHOUSE INVESTMENT MANAGEMENT, LTD.
1/30
01:29 pm
avbp
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: VANGUARD GROUP INC
1/21
12:31 pm
avbp
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: BlackRock, Inc.
Low
Report
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: BlackRock, Inc.
11/14
04:53 pm
avbp
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: Octagon Capital Advisors LP
Low
Report
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: Octagon Capital Advisors LP
11/10
08:02 am
avbp
Form 10-Q ArriVent BioPharma, Inc. For: Sep 30
Low
Report
Form 10-Q ArriVent BioPharma, Inc. For: Sep 30
11/10
08:00 am
avbp
Form 8-K ArriVent BioPharma, Inc. For: Nov 10
Low
Report
Form 8-K ArriVent BioPharma, Inc. For: Nov 10